Immune evasion often occurs through the mechanism of peripheral tissue tolerance in cancers, for example, inhibiting the expression of programmed cell death ligand 1 (PD-L1) can produce potent anti-tumor immunity [72]. This evidence concerns the gene CD274 and cancer.